title: [Rational treatment of Crohn's disease].
authors.affiliation: Medizinische Klinik 1, Universitätsklinik Erlangen. raja.atreya@uk-erlangen.de
authors.forename: R
authors.initials: R
authors.lastname: Atreya
authors.forename: H
authors.initials: H
authors.lastname: Neumann
authors.forename: M F
authors.initials: MF
authors.lastname: Neurath
mesh_terms: D000284:Administration, Oral; D000287:Administration, Topical; D000465:Algorithms; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D019819:Budesonide / Q000008:administration & dosage; D002432:Cecum; D003424:Crohn Disease / Q000145:classification / Q000150:complications / Q000628:therapy*; D016099:Endoscopy, Gastrointestinal; D006801:Humans; D007082:Ileum; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D055502:Secondary Prevention; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D019819:Budesonide; D011239:Prednisolone; D008727:Methotrexate